STRR vs. CLGN, COCH, RVP, ICU, NRXS, DRIO, PETV, IRIX, OSRH, and NXGL
Should you be buying Hudson Global stock or one of its competitors? The main competitors of Hudson Global include CollPlant Biotechnologies (CLGN), Envoy Medical (COCH), Retractable Technologies (RVP), SeaStar Medical (ICU), NeurAxis (NRXS), DarioHealth (DRIO), PetVivo (PETV), IRIDEX (IRIX), OSR (OSRH), and NexGel (NXGL). These companies are all part of the "medical equipment" industry.
Hudson Global vs. Its Competitors
Hudson Global (NASDAQ:STRR) and CollPlant Biotechnologies (NASDAQ:CLGN) are both small-cap medical equipment companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, dividends, risk, institutional ownership, earnings, media sentiment, analyst recommendations and profitability.
Hudson Global has a beta of 0.37, indicating that its share price is 63% less volatile than the S&P 500. Comparatively, CollPlant Biotechnologies has a beta of 1.61, indicating that its share price is 61% more volatile than the S&P 500.
Hudson Global has a net margin of -2.81% compared to CollPlant Biotechnologies' net margin of -541.34%. Hudson Global's return on equity of -3.81% beat CollPlant Biotechnologies' return on equity.
In the previous week, CollPlant Biotechnologies had 3 more articles in the media than Hudson Global. MarketBeat recorded 3 mentions for CollPlant Biotechnologies and 0 mentions for Hudson Global. CollPlant Biotechnologies' average media sentiment score of 0.33 beat Hudson Global's score of 0.00 indicating that CollPlant Biotechnologies is being referred to more favorably in the news media.
Hudson Global currently has a consensus price target of $5.00, suggesting a potential downside of 47.03%. CollPlant Biotechnologies has a consensus price target of $11.50, suggesting a potential upside of 309.54%. Given CollPlant Biotechnologies' stronger consensus rating and higher probable upside, analysts plainly believe CollPlant Biotechnologies is more favorable than Hudson Global.
47.2% of Hudson Global shares are held by institutional investors. Comparatively, 21.7% of CollPlant Biotechnologies shares are held by institutional investors. 10.4% of Hudson Global shares are held by insiders. Comparatively, 9.6% of CollPlant Biotechnologies shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Hudson Global has higher revenue and earnings than CollPlant Biotechnologies. Hudson Global is trading at a lower price-to-earnings ratio than CollPlant Biotechnologies, indicating that it is currently the more affordable of the two stocks.
Summary
Hudson Global and CollPlant Biotechnologies tied by winning 8 of the 16 factors compared between the two stocks.
Get Hudson Global News Delivered to You Automatically
Sign up to receive the latest news and ratings for STRR and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding STRR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Hudson Global Competitors List
Related Companies and Tools
This page (NASDAQ:STRR) was last updated on 9/7/2025 by MarketBeat.com Staff
Free STRR Stock Alerts